BELLICUM PHARMACEUTICALS, INC·4

Sep 2, 10:29 AM ET

Huber Reid M 4

4 · BELLICUM PHARMACEUTICALS, INC · Filed Sep 2, 2022

Insider Transaction Report

Form 4
Period: 2022-09-01
Huber Reid M
Director
Transactions
  • Exercise/Conversion

    Common Stock

    2022-09-01+46,48965,983 total
Footnotes (1)
  • [F1]The Reporting Person was granted Restricted Stock Units ("RSUs"). Each RSU represents a contingent right to receive one share of BLCM common stock. The RSUs vest in full on September 1, 2023, the one-year anniversary of the grant date.

Documents

1 file
  • 4
    wf-form4_166212897072850.xmlPrimary

    FORM 4